Companies /Healthcare
Biomarin Pharmaceutical Inc
NASDAQ: BMRN Biotechnology
$55.20
▼ $1.02 (−1.81%) today
Markets closed · 7:39pm ET

BioMarin (BMRN) Earnings History & Trends

EPS and revenue vs. Street estimates · SEC filings
40%
EPS beat rate
−7.23%
Avg. EPS surprise
Consecutive EPS misses
BMRN vs Market · 30-day return after each reportBMRNS&P 500
−12%−6%0%+6%−9.5%+5.2%Q1 25−6.7%+3.1%Q2 25+4.6%−0.5%Q3 25−11.3%−6.2%Q4 25+6.6%+1.9%Q1 26
−12%−6%0%+6%Q1 25Q2 25Q3 25Q4 25Q1 26
BMRN EPS Trend · estimate vs actualEstimateActual
$0.00$0.40$0.80$1.20$0.95$1.13Q1 25$1.01$1.44Q2 25$0.32$0.12Q3 25$0.56$0.46Q4 25$0.91$0.76Q1 26
$0.00$0.40$0.80$1.20Q1 25Q2 25Q3 25Q4 25Q1 26
BMRN Revenue Trend · estimate vs actualEstimateActual
$0$300.0M$600.0M$900.0M$738.4M$745.1MQ1 25$761.7M$825.4MQ2 25$780.2M$776.1MQ3 25$835.0M$874.6MQ4 25$751.7M$766.2MQ1 26
$0$300.0M$600.0M$900.0MQ1 25Q2 25Q3 25Q4 25Q1 26

How Often Does BioMarin Beat Earnings Estimates?

BioMarin beat EPS estimates in 2 of its last 5 reported quarters, and has missed 3 quarters in a row.

BMRN quarterly earnings per share and revenue versus Street estimates
Quarter EPS · est. Surprise Revenue · est. Surprise
Q1 2026 $0.76 est. $0.91 −16.86% $766.2M est. $751.7M +1.93%
Q4 2025 $0.46 est. $0.56 −17.95% $874.6M est. $835.0M +4.73%
Q3 2025 $0.12 est. $0.32 −62.50% $776.1M est. $780.2M −0.52%
Q2 2025 $1.44 est. $1.01 +42.31% $825.4M est. $761.7M +8.37%
Q1 2025 $1.13 est. $0.95 +18.87% $745.1M est. $738.4M +0.91%

Figures from SEC filings and company reports. Not investment advice.